| Stage | ABG | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.4B | 100.00% | $8.0B | 100.00% | CVNA ×1.82 |
| Gross profit | $732M | 16.57% | $1.5B | 18.92% | CVNA +2.3pp |
| Operating income | $207M | 4.68% | $714M | 8.88% | CVNA +4.2pp |
| Pre-tax income | $139M | 3.15% | $552M | 6.87% | CVNA +3.7pp |
| Net income | $105M | 2.38% | $483M | 6.01% | CVNA +3.6pp |
| Stage | ABG | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $4.4B100.00% | $8.0B100.00% | CVNA ×1.82 |
| Gross profit | 16.57%$732M | 18.92%$1.5B | CVNA +2.3pp |
| Operating income | 4.68%$207M | 8.88%$714M | CVNA +4.2pp |
| Pre-tax income | 3.15%$139M | 6.87%$552M | CVNA +3.7pp |
| Net income |
| 2.38%$105M |
| 6.01%$483M |
| CVNA +3.6pp |
None
No disclosed counterparties: ABG.